MKPL · M K Proteins Ltd · Food Processing
MKPL · M K Proteins Ltd · Food Processing
As of 05 Nov close
52-week range
43.9% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹115 Cr
Revenue YoY
PAT YoY
-60.7%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
2
P/S (TTM)
0.4
Sector P/E
21.7
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| MKPL (this stock) | 35.9 | 2 | +1.2% | +6.2% | 0.49 | 0.0% |
| Nestle India | 71 | 50.7 | +15.6% | +73.9% | 0.09 | +0.9% |
| Britannia Industries | 47.6 | 24.1 | +13.3% | +51.0% | 0.27 | +1.8% |
| Tata Consumer Products | 67.4 | 4.9 | +8.1% | +7.4% | 4.18 | +0.9% |
Promoter
stable
FII
stable
MF
Not available from data source
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
AI Summary of Annual Report
AI-generatedM K Proteins Limited's annual report for FY2025-26 outlines the company's operational and financial performance, corporate governance practices, and risk management strategies. The report highlights the company's focus on maintaining internal financial controls, adherence to regulatory requirements, and the appointment of an additional independent director to strengthen the board's composition. The report also discusses the company's risk management framework, including strategic, compliance, financial, environmental, operational, and social risks. Additionally, the report provides details on the company's financial performance, including revenue growth and challenges in maintaining profitability.
- The company has appointed an additional independent director to strengthen the board's composition and governance framework.
- The company has implemented a structured risk management framework to identify, assess, and manage risks systematically.
- The company has focused on maintaining internal financial controls and ensuring compliance with regulatory requirements.
- The company has experienced revenue growth but faces challenges in maintaining profitability due to increased operating costs and other expenses.
Key takeaway: M K Proteins Limited has strengthened its board governance by appointing an additional independent director and has implemented a structured risk management framework to address various operational and financial risks.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Auditor Qualification (1 item); Regulatory Action (1 item)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Auditor Qualification
1 occurrenceEarlier (1-3 years ago)
M/s KRA & Co. Chartered Accountants resigned as statutory auditors of M K Proteins Limited before completing their term, causing a casual vacancy. The resignation was communicated on August 4, 2025.
Regulatory Action
1 occurrenceRecent (last 12 months)
The company incurred a fine and penalty amounting to Rs. NIL for the year ended 31 March 2025 related to stock exchange annual listing fees.
Routine disclosures
Contingent Liability
2 occurrencesRecent (last 12 months)
The company has contingent liabilities from pending income tax appeals for Assessment Years 2016–17 to 2018–19 and GST demand proceedings for FY 2019–20, against which appeals have been filed.
Earlier (1-3 years ago)
The company has contingent liabilities related to income tax litigation, with management's counsel indicating that many of the revenue's issues may not be sustainable in law.
Related-Party Transaction
2 occurrencesRecent (last 12 months)
The company has conducted transactions with related parties, including M/s Kamla Oleo Private Limited and M/s Kamla Oils and Fats Private Limited, as well as individuals like Mr. Vinod Kumar, involving trade payables, advances to suppliers, and other creditors as of March 31, 2026.
Earlier (1-3 years ago)
The excerpt mentions details of related party transactions, such as contributions to a trust.
Statutory dues in dispute
2 occurrencesRecent (last 12 months)
The company has not deposited certain statutory dues under the Income Tax Act and Goods and Services Tax Act due to disputes, with amounts pending before the Commissioner of Income Tax (Appeals) and Appellate Authority.
Earlier (1-3 years ago)
The company has statutory dues under the Income Tax Act for the years 2015-16 to 2018-19 pending before the Commissioner of Income Tax (Appeals), with amounts totaling Rs.91.75 Lacs net of payments made under protest.
Management & Board Governance
2 occurrencesRecent (last 12 months)
Ms. Laxmi Mandal resigned as a director of M K Proteins Limited on 12th August 2026.
Earlier (1-3 years ago)
Ms. Swati Gupta resigned from the post of Independent Director of M K Proteins Limited with effect from 13th August, 2025.